Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
VisionTech Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
VisionTech Partners

VisionTech Partners

Operating

VisionTech Partners LLC: A US-based tech investment firm, funding ventures in IT, agriculture, and manufacturing.

Location
Indianapolis, IN, US
Founded
2009
Firm
Compare
Portfolio
Employees
Website

Investments

Adipo Therapeutics
Adipo Therapeutics

Total Raised

$3.3M

Rounds

3

Convertible Note$1.9MJanuary 2024
Laxis
Laxis

Total Raised

$1.5M

Rounds

4

Seed$1.5MOctober 2023
Stamus Networks
Stamus Networks

Total Raised

$7.5M

Rounds

2

Series A$6MAugust 2023
Seed$1.5MApril 2020
Flyte
Flyte

Total Raised

$4.5M

Rounds

4

Seed$2.7MAugust 2023
Nexosome Oncology
Nexosome Oncology

Total Raised

$3.7M

Rounds

1

Seed$3.7MNovember 2021
Augment Therapy
Augment Therapy

Total Raised

$4.4M

Rounds

5

Seed$1.4MSeptember 2021
Resonado Labs
Resonado Labs
Seed

Total Raised

$5.5M

Rounds

7

Seed$3MJuly 2021
Angel$210kAugust 2020
OnStation
OnStation

Total Raised

$1.5M

Rounds

2

Seed$1.4MJuly 2021
Toralgen
Toralgen

Total Raised

$10.2M

Rounds

2

Seed$8.3MDecember 2020
Seed$1.9MSeptember 2019
Ateios
Ateios
Series Unknown

Total Raised

$1.5M

Rounds

4

Seed$1.3MOctober 2020
Spintech
Spintech

Total Raised

$5.5M

Rounds

5

Angel$155kSeptember 2020
MITO Material Solutions
MITO Material Solutions

Total Raised

$6.9M

Rounds

6

Seed$1MAugust 2020
Atlas Energy Systems
Atlas Energy Systems

Total Raised

$558k

Rounds

3

Series A$558kDecember 2019
PhotoniCare
PhotoniCare

Total Raised

$18.2M

Rounds

15

Seed$2MMarch 2018
Bolstra
Bolstra
Acquired

Total Raised

$4.5M

Rounds

3

Seed$1.5MFebruary 2018
SonarMed
SonarMed

Total Raised

$12.1M

Rounds

7

Series C$3MOctober 2017
Inscope Medical Solutions
Inscope Medical Solutions
Acquired

Total Raised

$2.5M

Rounds

5

Seed$2.3MSeptember 2017
Tenant Tracker
Tenant Tracker

Total Raised

$996k

Rounds

2

Seed$600kMay 2017
Allotrope Medical
Allotrope Medical
Acquired

Total Raised

$5.3M

Rounds

8

SeedApril 2017
Realync
Realync

Total Raised

$23.4M

Rounds

5

Seed$1.1MOctober 2016
PivotCX.io
PivotCX.io
Acquired

Total Raised

$2.5M

Rounds

3

Seed$1.7MMarch 2016
Akadeum Life Sciences
Akadeum Life Sciences

Total Raised

$21.5M

Rounds

9

Seed$150kOctober 2014